Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
FONAR Co. stock logo
FONR
FONAR
$13.90
-1.7%
$14.91
$13.27
$21.25
$86.22M1.2716,556 shs7,505 shs
Lucid Diagnostics Inc. stock logo
LUCD
Lucid Diagnostics
$1.58
-0.6%
$1.27
$0.63
$1.63
$93.76M1.34362,517 shs701,358 shs
Monogram Orthopaedics, Inc. stock logo
MGRM
Monogram Orthopaedics
$2.79
-6.7%
$2.66
$1.82
$4.90
$98.46M1.66289,835 shs92,586 shs
SurgePays, Inc. stock logo
SURG
SurgePays
$1.79
-17.9%
$1.42
$1.05
$4.38
$36.09M1.03617,413 shs2.55 million shs
Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
FONAR Co. stock logo
FONR
FONAR
0.00%+0.43%-5.76%-7.02%-36.21%
Lucid Diagnostics Inc. stock logo
LUCD
Lucid Diagnostics
0.00%+3.95%+5.33%+100.00%+59.60%
Monogram Orthopaedics, Inc. stock logo
MGRM
Monogram Orthopaedics
0.00%-12.26%+25.11%+6.90%+20.78%
SurgePays, Inc. stock logo
SURG
SurgePays
0.00%+33.58%+43.20%-2.19%-52.01%
Remove Ads
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
FONAR Co. stock logo
FONR
FONAR
1.235 of 5 stars
0.03.00.00.02.00.81.9
Lucid Diagnostics Inc. stock logo
LUCD
Lucid Diagnostics
3.0461 of 5 stars
3.65.00.00.01.81.70.6
Monogram Orthopaedics, Inc. stock logo
MGRM
Monogram Orthopaedics
2.8651 of 5 stars
3.83.00.00.02.71.70.6
SurgePays, Inc. stock logo
SURG
SurgePays
3.0595 of 5 stars
3.55.00.00.02.21.70.6
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
FONAR Co. stock logo
FONR
FONAR
0.00
N/AN/AN/A
Lucid Diagnostics Inc. stock logo
LUCD
Lucid Diagnostics
3.20
Buy$3.40115.19% Upside
Monogram Orthopaedics, Inc. stock logo
MGRM
Monogram Orthopaedics
3.50
Strong Buy$5.4093.55% Upside
SurgePays, Inc. stock logo
SURG
SurgePays
3.00
Buy$8.50374.86% Upside

Current Analyst Ratings Breakdown

Latest SURG, MGRM, LUCD, and FONR Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
3/26/2025
Lucid Diagnostics Inc. stock logo
LUCD
Lucid Diagnostics
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$2.00 ➝ $2.00
3/25/2025
Lucid Diagnostics Inc. stock logo
LUCD
Lucid Diagnostics
BTIG Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Price Target$2.00
3/24/2025
Lucid Diagnostics Inc. stock logo
LUCD
Lucid Diagnostics
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$2.50 ➝ $3.00
3/18/2025
Monogram Orthopaedics, Inc. stock logo
MGRM
Monogram Orthopaedics
Roth Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Price Target$5.40
3/18/2025
Monogram Orthopaedics, Inc. stock logo
MGRM
Monogram Orthopaedics
Roth Mkm
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$4.00 ➝ $5.40
(Data available from 3/30/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
FONAR Co. stock logo
FONR
FONAR
$101.57M0.85$2.91 per share4.78$25.62 per share0.54
Lucid Diagnostics Inc. stock logo
LUCD
Lucid Diagnostics
$4.35M21.57N/AN/A($0.47) per share-3.36
Monogram Orthopaedics, Inc. stock logo
MGRM
Monogram Orthopaedics
$365.00K269.74N/AN/A$0.43 per share6.49
SurgePays, Inc. stock logo
SURG
SurgePays
$60.88M0.59$1.64 per share1.09$1.68 per share1.07
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
FONAR Co. stock logo
FONR
FONAR
$10.57M$1.1512.09N/A7.68%4.94%3.70%5/13/2025 (Estimated)
Lucid Diagnostics Inc. stock logo
LUCD
Lucid Diagnostics
-$52.67M-$1.08N/AN/AN/A-1,069.87%N/A-123.54%5/12/2025 (Estimated)
Monogram Orthopaedics, Inc. stock logo
MGRM
Monogram Orthopaedics
-$13.74M-$0.46N/AN/AN/AN/A-130.90%-106.38%N/A
SurgePays, Inc. stock logo
SURG
SurgePays
$20.62M-$2.34N/AN/AN/A-27.39%-55.63%-43.61%5/12/2025 (Estimated)

Latest SURG, MGRM, LUCD, and FONR Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
3/25/2025Q4 2024
SurgePays, Inc. stock logo
SURG
SurgePays
-$0.27-$0.93-$0.66-$1.02$8.22 million$9.59 million
3/12/2025Q4 2024
Monogram Orthopaedics, Inc. stock logo
MGRM
Monogram Orthopaedics
-$0.11-$0.08+$0.03-$0.08N/AN/A
2/19/2025Q2 2025
FONAR Co. stock logo
FONR
FONAR
N/A$0.29N/A$0.29N/A$24.95 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
FONAR Co. stock logo
FONR
FONAR
N/AN/AN/AN/AN/A
Lucid Diagnostics Inc. stock logo
LUCD
Lucid Diagnostics
N/AN/AN/AN/AN/A
Monogram Orthopaedics, Inc. stock logo
MGRM
Monogram Orthopaedics
N/AN/AN/AN/AN/A
SurgePays, Inc. stock logo
SURG
SurgePays
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
FONAR Co. stock logo
FONR
FONAR
N/A
11.24
9.45
Lucid Diagnostics Inc. stock logo
LUCD
Lucid Diagnostics
N/A
1.18
1.14
Monogram Orthopaedics, Inc. stock logo
MGRM
Monogram Orthopaedics
N/A
7.31
7.31
SurgePays, Inc. stock logo
SURG
SurgePays
0.08
6.24
4.70

Institutional Ownership

CompanyInstitutional Ownership
FONAR Co. stock logo
FONR
FONAR
50.64%
Lucid Diagnostics Inc. stock logo
LUCD
Lucid Diagnostics
74.01%
Monogram Orthopaedics, Inc. stock logo
MGRM
Monogram Orthopaedics
0.45%
SurgePays, Inc. stock logo
SURG
SurgePays
6.94%

Insider Ownership

CompanyInsider Ownership
FONAR Co. stock logo
FONR
FONAR
2.17%
Lucid Diagnostics Inc. stock logo
LUCD
Lucid Diagnostics
8.80%
Monogram Orthopaedics, Inc. stock logo
MGRM
Monogram Orthopaedics
28.10%
SurgePays, Inc. stock logo
SURG
SurgePays
29.40%
CompanyEmployeesShares OutstandingFree FloatOptionable
FONAR Co. stock logo
FONR
FONAR
4806.20 million6.19 millionNot Optionable
Lucid Diagnostics Inc. stock logo
LUCD
Lucid Diagnostics
7059.34 million54.12 millionNo Data
Monogram Orthopaedics, Inc. stock logo
MGRM
Monogram Orthopaedics
2835.29 million24.67 millionNot Optionable
SurgePays, Inc. stock logo
SURG
SurgePays
4020.16 million14.23 millionOptionable

Recent News About These Companies

Critical Contrast: BCE (NYSE:BCE) and SurgePays (NASDAQ:SURG)
Research Analysts Set Expectations for SurgePays Q1 Earnings
Sidoti Csr Weighs in on SurgePays' Q4 Earnings (NASDAQ:SURG)
SurgePays And 2 Other Promising Penny Stocks To Watch
SurgePays sees FY25 revenue $200M, consensus $95.11M
Q4 2024 Surgepays Inc Earnings Call
SurgePays Sees Unusually Large Options Volume (NASDAQ:SURG)
SurgePays Shares Soar on Revenue Outlook
SurgePays (SURG) Projected to Post Earnings on Tuesday

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
FONAR stock logo

FONAR NASDAQ:FONR

$13.90 -0.24 (-1.70%)
Closing price 03/28/2025 04:00 PM Eastern
Extended Trading
$13.96 +0.06 (+0.47%)
As of 03/28/2025 04:01 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

FONAR Corporation, together with its subsidiaries, engages in the research, development, production, and marketing of magnetic resonance imaging (MRI) scanners for the detection and diagnosis of human diseases in the United States. The company operates in two segments, Medical Equipment, and Physician Management and Diagnostic Services. It provides Upright MRI scanner that allows patients to be scanned in weight-bearing conditions, such as standing, sitting, bending, or lying down. The company also offers non-medical management, including administrative services, billing and collection services, credentialing services, contract negotiations, compliance consulting, purchasing IT services, hiring, conducting interviews, training, supervision and management of non-medical personnel, storage of medical records, office space, equipment, repair maintenance services, accounting, assistance with compliance matters, and development and implementation of practice growth and marketing strategies. It owns and operates diagnostic imaging facilities in Florida; and manages MRI scanning facilities. The company markets its scanners to private diagnostic imaging centers and hospital outpatient imaging facilities. FONAR Corporation was founded in 1970 and is based in Melville, New York.

Lucid Diagnostics stock logo

Lucid Diagnostics NASDAQ:LUCD

$1.58 -0.01 (-0.63%)
Closing price 03/28/2025 04:00 PM Eastern
Extended Trading
$1.58 +0.00 (+0.32%)
As of 03/28/2025 07:37 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Lucid Diagnostics Inc. operates as a commercial-stage medical diagnostics technology company in the United States. The company focuses on patients with gastroesophageal reflux disease (GERD) who are at risk of developing esophageal precancer and cancer, primarily highly lethal esophageal adenocarcinoma. Its flagship product, the EsoGuard Esophageal DNA Test performed on samples collected with the EsoCheck Esophageal Cell collection device, a testing tool with the goal of preventing EAC deaths through early detection of esophageal precancer in at-risk GERD patients. The company was incorporated in 2018 and is based in New York, New York. Lucid Diagnostics Inc. is a subsidiary of PAVmed Inc.

Monogram Orthopaedics stock logo

Monogram Orthopaedics NASDAQ:MGRM

$2.79 -0.20 (-6.69%)
Closing price 03/28/2025 04:00 PM Eastern
Extended Trading
$2.92 +0.14 (+4.84%)
As of 03/28/2025 07:52 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Monogram Orthopaedics, Inc. focuses on developing a product solution architecture to enable patient-optimized orthopaedic implants. The company intends to produce and market robotic surgical equipment and related software, orthopedic implants, tissue ablation tools, navigation consumables, and other miscellaneous instrumentation for use in reconstructive joint replacement procedures. Its robot prototype executes optimized paths for high-precision insertion of optimized implants in synthetic bone specimens. The company was formerly known as Monogram Arthroplasty Inc. and changed its name to Monogram Orthopaedics, Inc. in March 2017. The company was founded in 2015 and is headquartered in Austin, Texas.

SurgePays stock logo

SurgePays NASDAQ:SURG

$1.79 -0.39 (-17.89%)
Closing price 03/28/2025 04:00 PM Eastern
Extended Trading
$1.85 +0.06 (+3.30%)
As of 03/28/2025 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

SurgePays, Inc., together with its subsidiaries, operates as a financial technology and telecom company in the United States. It operates through three segments: Mobile Virtual Network Operators, Comprehensive Platform Services, and Lead Generation. The company offers subsidized and non-subsidized mobile virtual network operators for internet connectivity through mobile broadband services to consumers; ACH banking relationships and fintech transactions platform to convenience stores; wireless top-up transactions and wireless product aggregation; and lead generation and case management solutions primarily to law firms in the mass tort industry, as well as call center activities. SurgePays, Inc. is headquartered in Bartlett, Tennessee.